Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it. - 2Trump announces 'Patriot Games' with 2 competitors from every state and territory: What we know
- 3Space station changes command, setting stage for Crew 11 departure
- 4High Court freezes government move to shutter Army Radio pending ruling
- 5Figure out How to Keep up with Oral Wellbeing During Pregnancy
- FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- The Job of a Migration Legal advisor: How They Can Help You
- Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- 4 Famous Attractions at Disneyland
- The largest sun of 2026 rises today as Earth draws closest to our parent star
- The Best Games On the planet
- Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- Machado ‘presented’ her Nobel Peace Prize medal to Trump
